526 related articles for article (PubMed ID: 24280021)
1. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid levels in Parkinson's disease and related disorders.
Sakuta H; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Watanabe Y; Hirata K
Brain Behav; 2017 Jan; 7(1):e00598. PubMed ID: 28127516
[TBL] [Abstract][Full Text] [Related]
3. Multiple system atrophy is associated with changes in peripheral insulin-like growth factor system.
Pellecchia MT; Pivonello R; Longo K; Manfredi M; Tessitore A; Amboni M; Pivonello C; Rocco M; Cozzolino A; Colao A; Barone P
Mov Disord; 2010 Nov; 25(15):2621-6. PubMed ID: 20683839
[TBL] [Abstract][Full Text] [Related]
4. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
[TBL] [Abstract][Full Text] [Related]
5. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
[TBL] [Abstract][Full Text] [Related]
6. Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Picillo M; Barone P; Erro R; Spina E; Pellecchia MT
Parkinsonism Relat Disord; 2014 Jun; 20(6):680-1. PubMed ID: 24630925
[No Abstract] [Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
8. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
9. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Ashour R; Jankovic J
Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
[TBL] [Abstract][Full Text] [Related]
10. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
Holmberg B; Rosengren L; Karlsson JE; Johnels B
Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
[TBL] [Abstract][Full Text] [Related]
11. Authors' reply to the comments of Picillo et al. regarding "Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy".
Suzuki K; Numao A; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Jun; 20(6):682-3. PubMed ID: 24709085
[No Abstract] [Full Text] [Related]
12. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
[TBL] [Abstract][Full Text] [Related]
13. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
[TBL] [Abstract][Full Text] [Related]
14. Acoustical analysis of speech in progressive supranuclear palsy.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
16. The circulating level of leptin and blood pressure in patients with multiple system atrophy.
Ozawa T; Tokunaga J; Arakawa M; Ishikawa A; Takeuchi R; Yokoseki A; Sone H; Nishizawa M
J Neurol Sci; 2014 Dec; 347(1-2):349-51. PubMed ID: 25304054
[TBL] [Abstract][Full Text] [Related]
17. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy.
Han YH; Lee JH; Kang BM; Mun CW; Baik SK; Shin YI; Park KH
J Neurol Sci; 2013 Feb; 325(1-2):29-35. PubMed ID: 23260321
[TBL] [Abstract][Full Text] [Related]
18. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Tong J; Fitzmaurice PS; Ang LC; Furukawa Y; Guttman M; Kish SJ
Ann Neurol; 2004 Jan; 55(1):125-9. PubMed ID: 14705122
[TBL] [Abstract][Full Text] [Related]
19. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.
Reginold W; Lang AE; Marras C; Heyn C; Alharbi M; Mikulis DJ
Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
